Dr Olu Bamgbade, MD, FRCPC
Quick facts
Phase 3 pipeline
- Magnesium Sulfate high dose · Neurology
High-dose magnesium sulfate acts as a NMDA receptor antagonist and stabilizes neuronal membranes, reducing excitotoxicity and seizure activity.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Dr Olu Bamgbade, MD, FRCPC
What is Dr Olu Bamgbade, MD, FRCPC's pipeline?
Dr Olu Bamgbade, MD, FRCPC has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Magnesium Sulfate high dose.
Related
- Sector hub: All tracked pharma companies